Arteris vs Ceva
Both are primarily Semiconductor IP Licensing companies. Arteris is larger by market cap ($1.1B vs $950M). Ceva reports higher tracked revenue ($88M vs $71M).
Track the chain
What moved in the semiconductor supply chain — This Week in the Chain, the free weekly wafergraph briefing.
Subscribe to the free weekly briefing →
Free · no login · 615 companies, updated weekly
Side-by-side
| Arteris | Ceva | |
|---|---|---|
| Market cap | $1.1B | $950M |
| Revenue | $71M (FY2025) | $88M (FY2017) |
| Primary segment | Semiconductor IP Licensing | Semiconductor IP Licensing |
| Market position | niche | niche |
| Country | United States | Israel |
| Tracked suppliers | 0 | 0 |
| Tracked customers | 8 | 9 |
| Chokepoint / criticality | 50/100 | 50/100 |
Market caps/revenue from the wafergraph dataset · data as of 2026-10-09. Criticality is a graph-derived chokepoint score (0–100). Coverage is partial; "Unpriced" means no reliable market cap.
How Arteris and Ceva compare
- Size: Arteris is the larger company by market cap.
- Revenue: Ceva reports higher tracked revenue.
- Supply-chain criticality: Both companies have the same chokepoint score (50/100).
- Footprint: Arteris (United States) vs Ceva (Israel).
Company hubs
Open the interactive comparison tool →
Cite as: wafergraph, “Arteris vs Ceva”, https://wafergraph.com/compare/arteris-vs-ceva (data as of 2026-10-09).
Frequently asked questions3
- Is Arteris bigger than Ceva?
- Arteris is larger by market cap ($1.1B vs $950M).
- What's the difference between Arteris and Ceva?
- Arteris is a niche in Semiconductor IP Licensing based in United States; Ceva is a niche in Semiconductor IP Licensing based in Israel. Both operate in the EDA & IP segment.
- Who are Arteris's and Ceva's suppliers?
- wafergraph tracks 0 suppliers for Arteris and 0 for Ceva.